ArticleOncotarget2017
Open access · diamondAbstract read
In one paragraph
Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.
0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
56 citing papers in PubMed, 81 citations in OpenAlex.
- STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells.International journal of hematology · 2019Trial
- Anti-PAD4 antibodies link autoimmunity to PAD4 with CTL-associated rheumatoid arthritis.Annals of the rheumatic diseases · 2026Article
- [A single-center study on the clinical characteristics of 15 cases of large granular lymphocytic leukemia].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2026Article
- STAT3 SH2 Domain Aspartic Acid 661 Mutations Activate Immune Gene Programs.Journal of cellular and molecular medicine · 2026Article
- Transcriptomic landscape of CD8+ and CD4 + T-LGL leukemia revealed the distinct impact of STAT3 and STAT5B activating mutations.Leukemia · 2025Article
- Research on the functions and potential mechanisms of STAT3 in chronic myelogenous leukemia.Discover oncology · 2025Article
- Pure Red Cell Aplasia in a Patient with Thymic Hyperplasia, Hypogammaglobulinemia and Adult T-cell Leukemia/Lymphoma.Internal medicine (Tokyo, Japan) · 2025Article
- Clinical features and outcomes in large granular lymphocyte leukemia - associated pure red cell aplasia with STAT3 mutation.Annals of hematology · 2025Article
- Classification of NK-large granular lymphocytic leukemia by CD56 expression.The oncologist · 2025Article
- T-cell clones of uncertain significance. When is the rogue clone dangerous?Haematologica · 2025Review
- Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation.Cancers · 2024Review
- Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment.Cancers · 2024Review
- The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders.Blood cancer journal · 2024Review
- Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia.Haematologica · 2024Article
- JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences.Journal of clinical immunology · 2023Review
- Context-dependent T-cell Receptor Gene Repertoire Profiles in Proliferations of T Large Granular Lymphocytes.HemaSphere · 2023Article
- Distinct mutational pattern of T-cell large granular lymphocyte leukemia combined with pure red cell aplasia: low mutational burden of STAT3.Scientific reports · 2023Article
- Article
- Tyrosine kinases in nodal peripheral T-cell lymphomas.Frontiers in oncology · 2023Review
- Genetics of Immune Dysregulation and Cancer Predisposition: Two Sides of the Same Coin.Clinical and experimental immunology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 3 institutions in 2 countries.
Antonella TeramoPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Gregorio BarilàPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Giulia CalabrettoPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Chiara ErcolinPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Thierry LamyDepartment of Clinical Hematology, University Hospital of Rennes, Rennes, France.
Aline MoignetDepartment of Clinical Hematology, University Hospital of Rennes, Rennes, France.
Mikael RousselBiology Department, University Hospital of Rennes, Rennes, France.
Cédric PastoretBiology Department, University Hospital of Rennes, Rennes, France.
Matteo LeoncinPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Cristina GattazzoPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Anna CabrelleVenetian Institute of Molecular Medicine (VIMM), Padua, Italy.
Elisa BoscaroPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Sara TeolatoPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Elisa PagninPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Tamara BernoPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Elena De MarchPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Monica FaccoPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Francesco PiazzaPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Livio TrentinPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Gianpietro SemenzatoPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
Renato ZambelloPadua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy.
University of Padua · ITVeneto Institute of Molecular Medicine · ITCentre Hospitalier Universitaire de Rennes · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
fas ligandimmunophenotypelarge granular lymphocyte leukemianeutropeniaSTAT3 mutation
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.